Addex Therapeutics

ADXN

2.9901.97% ( -0.060 )

Closed: Oct 21, 16:00:00 (EDT)

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Addex Therapeutics(ADXN) the Revenue is 12.31 K (-73.14%);the EBIT is -798.73 K (+13.53%);the EPS is -2.11 (+23.7%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

0.00B73.14%

----

----

EBIT

-0.00B13.53%

----

----

EPS

-2.113623.70%

----

----

Upcoming earnings report - FY2026 Q3 Earning Release

Available dateNov 9, 2026

Estimate Revenue--

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: USD

Quarterly

EBIT

ActualEstimateUnit: USD

Quarterly

Net income

ActualEstimateUnit: USD

Quarterly

EPS

ActualEstimateUnit: USD

Quarterly